Register entry

Novartis Pharmaceuticals Corporation

Registered sites
20
Drug products
210
Live patents
329
Countries
11
Base
Switzerland
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackagingparticle size reduction
Sites

Facilities

20
SiteLocationOperationsFEI
Novartis Pharmaceutical Manufacturing GmbHKundlAustriaAnalytical testing, Active ingredient (API) manufacture3027031635
Novartis Pharmaceutical Manufacturing GmbHLangkampfenAustriaAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3027031650
Novartis Manufacturing NVPuurs-Sint-AmandsBelgiumLabelling, Finished drug manufacture, Packaging3002037047
Novartis Pharma AGBaselSwitzerlandAnalytical testing, Active ingredient (API) manufacture, Finished drug manufacture3002807772
Pharmanalytica SALocarnoSwitzerlandAnalytical testing3002807773
Novartis Pharma Schweizerhalle AGPratteln CHSwitzerlandAnalytical testing, Active ingredient (API) manufacture, Finished drug manufacture, particle size reduction3002865753
Novartis Pharma Stein AGSteinSwitzerlandAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3002653483
Novartis Pharma Produktions GmbHWehrGermanyAnalytical testing, Labelling, Finished drug manufacture, Packaging3000978864
NOVARTIS PHARMA SASHuningueFranceAnalytical testing, Active ingredient (API) manufacture3004864869
NOVARTIS FARMA SPATorre AnnunziataItalyAnalytical testing, Finished drug manufacture3002807747
Novartis Pharmaceuticals S.R.L.Targu MuresRomaniaAnalytical testing, Finished drug manufacture, Packaging3005587283
Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd.SingaporeSingaporeAnalytical testing, Active ingredient (API) manufacture, Finished drug manufacture3012958979
Novartis d.o.o.LjubljanaSloveniaAnalytical testing, Labelling, Finished drug manufacture, Packaging, particle size reduction3013358387
Novartis d.o.o.MengesSloveniaAnalytical testing, Active ingredient (API) manufacture, Finished drug manufacture3002807470
DSV Contract Logistics d.d.Skofja LokaSloveniaAnalytical testing3027330334
Novartis Saglik, Gida Ve Tarim Urunleri Sanayi Ve Ticaret Anonim SirketiIstanbulTurkeyAnalytical testing, Finished drug manufacture3004121450
Novartis Manufacturing LLCCarlsbad, CAUnited StatesAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3013510604
Novartis Manufacturing LLCIndianapolis, INUnited StatesAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3019881323
Novartis Manufacturing LLCIndianapolis, INUnited StatesAnalytical testing, Active ingredient (API) manufacture3038913659
Novartis Pharmaceuticals CorporationMorris Plains, NJUnited StatesAnalytical testing, Labelling, Finished drug manufacture, Packaging3010353512
Exclusivity

Patents

329

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
AFINITOREVEROLIMUSJul 2028
ARCAPTA NEOHALERINDACATEROL MALEATEOct 2028
ENTRESTOSACUBITRIL; VALSARTANNov 2026
ENTRESTOSACUBITRIL; VALSARTANMay 2027
ENTRESTOSACUBITRIL; VALSARTANMay 2027
ENTRESTOSACUBITRIL; VALSARTANNov 2027
ENTRESTOSACUBITRIL; VALSARTANAug 2033
ENTRESTOSACUBITRIL; VALSARTANMay 2036
ENTRESTO SPRINKLESACUBITRIL; VALSARTANNov 2026
ENTRESTO SPRINKLESACUBITRIL; VALSARTANMay 2027
ENTRESTO SPRINKLESACUBITRIL; VALSARTANFeb 2037
FABHALTAIPTACOPAN HYDROCHLORIDEJul 2034
FABHALTAIPTACOPAN HYDROCHLORIDEAug 2038
FABHALTAIPTACOPAN HYDROCHLORIDEMay 2041
FABHALTAIPTACOPAN HYDROCHLORIDEMay 2041
FABHALTAIPTACOPAN HYDROCHLORIDEJul 2041
GILENYAFINGOLIMOD HYDROCHLORIDEDec 2027
GILENYAFINGOLIMOD HYDROCHLORIDEMar 2032
GILENYAFINGOLIMOD HYDROCHLORIDESept 2032
IZBATRAVOPROSTMar 2029
IZBATRAVOPROSTMay 2029
IZBATRAVOPROSTOct 2029
JADENUDEFERASIROXNov 2034
KISQALIRIBOCICLIB SUCCINATEJun 2028
KISQALIRIBOCICLIB SUCCINATEDec 2028
KISQALIRIBOCICLIB SUCCINATEAug 2029
KISQALIRIBOCICLIB SUCCINATEDec 2029
KISQALIRIBOCICLIB SUCCINATEFeb 2030
KISQALIRIBOCICLIB SUCCINATEMay 2030
KISQALIRIBOCICLIB SUCCINATEJun 2030
KISQALIRIBOCICLIB SUCCINATENov 2030
KISQALIRIBOCICLIB SUCCINATEMar 2031
KISQALIRIBOCICLIB SUCCINATESept 2031
KISQALIRIBOCICLIB SUCCINATENov 2031
KISQALIRIBOCICLIB SUCCINATEMay 2032
KISQALIRIBOCICLIB SUCCINATEAug 2034
KISQALIRIBOCICLIB SUCCINATEFeb 2035
KISQALIRIBOCICLIB SUCCINATEApr 2036
KISQALIRIBOCICLIB SUCCINATEOct 2036
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATEJun 2028
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATEDec 2028
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATEAug 2029
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATEDec 2029
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATEFeb 2030
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATEMay 2030
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATEJun 2030
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATENov 2030
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATEMar 2031
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATESept 2031
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATENov 2031
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATEMay 2032
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATEAug 2034
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATEFeb 2035
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATEApr 2036
KISQALI FEMARA CO-PACK (COPACKAGED)LETROZOLE; RIBOCICLIB SUCCINATEOct 2036
LEQVIOINCLISIRAN SODIUMMay 2027
LEQVIOINCLISIRAN SODIUMDec 2027
LEQVIOINCLISIRAN SODIUMAug 2028
LEQVIOINCLISIRAN SODIUMDec 2028
LEQVIOINCLISIRAN SODIUMDec 2029
Catalogue

Marketed products

210

Showing 150 of 210.

BrandGeneric nameFormCategory
ADAKVEOcrizanlizumabINJECTIONBLA
AfinitoreverolimusTABLETNDA
AfinitoreverolimusTABLETNDA
AfinitoreverolimusTABLETNDA
AfinitoreverolimusTABLETNDA
Afinitor DisperzeverolimusTABLET, FOR SUSPENSIONNDA
Afinitor DisperzeverolimusTABLET, FOR SUSPENSIONNDA
Afinitor DisperzeverolimusTABLET, FOR SUSPENSIONNDA
ArranonnelarabineINJECTIONNDA
BEOVUbrolucizumabINJECTION, SOLUTIONBLA
Betoptic Sbetaxolol hydrochlorideSUSPENSION/ DROPSNDA
-CANAKINUMABLIQUIDBULK INGREDIENT
COARTEMartemether and lumefantrineTABLETNDA
COSENTYXsecukinumabINJECTIONBLA
COSENTYXsecukinumabINJECTIONBLA
COSENTYXsecukinumabINJECTIONBLA
COSENTYXsecukinumabINJECTION, SOLUTION, CONCENTRATEBLA
-ClarithromycinPELLETDRUG FOR FURTHER PROCESSING
Desferaldeferoxamine mesylateINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONNDA
DiovanvalsartanTABLETNDA
DiovanvalsartanTABLETNDA
DiovanvalsartanTABLETNDA
DiovanvalsartanTABLETNDA
DiovanvalsartanTABLETNDA
DiovanvalsartanTABLETNDA
DiovanvalsartanTABLETNDA
Diovan HCTvalsartan and hydrochlorothiazideTABLET, FILM COATEDNDA
Diovan HCTvalsartan and hydrochlorothiazideTABLET, FILM COATEDNDA
Diovan HCTvalsartan and hydrochlorothiazideTABLET, FILM COATEDNDA
Diovan HCTvalsartan and hydrochlorothiazideTABLET, FILM COATEDNDA
Diovan HCTvalsartan and hydrochlorothiazideTABLET, FILM COATEDNDA
EGATENtriclabendazoleTABLETNDA
ENTRESTOSacubitril and ValsartanTABLET, FILM COATEDNDA
ENTRESTOSacubitril and ValsartanTABLET, FILM COATEDNDA
ENTRESTOSacubitril and ValsartanTABLET, FILM COATEDNDA
ENTRESTOSacubitril and ValsartanPELLETNDA
ENTRESTOSacubitril and ValsartanPELLETNDA
ENTRESTOSacubitril and ValsartanTABLET, FILM COATEDNDA
ENTRESTOSacubitril and ValsartanTABLET, FILM COATEDNDA
ExelonrivastigminePATCH, EXTENDED RELEASENDA
ExelonrivastigminePATCH, EXTENDED RELEASENDA
ExelonrivastigminePATCH, EXTENDED RELEASENDA
Exforgeamlodipine besylate and valsartanTABLET, FILM COATEDNDA
Exforgeamlodipine besylate and valsartanTABLET, FILM COATEDNDA
Exforgeamlodipine besylate and valsartanTABLET, FILM COATEDNDA
Exforgeamlodipine besylate and valsartanTABLET, FILM COATEDNDA
Exforge HCTamlodipine valsartan and hydrochlorothiazideTABLET, FILM COATEDNDA
Exforge HCTamlodipine valsartan and hydrochlorothiazideTABLET, FILM COATEDNDA
Exforge HCTamlodipine valsartan and hydrochlorothiazideTABLET, FILM COATEDNDA
Exforge HCTamlodipine valsartan and hydrochlorothiazideTABLET, FILM COATEDNDA
Exforge HCTamlodipine valsartan and hydrochlorothiazideTABLET, FILM COATEDNDA
ExjadedeferasiroxTABLET, FOR SUSPENSIONNDA
ExjadedeferasiroxTABLET, FOR SUSPENSIONNDA
ExjadedeferasiroxTABLET, FOR SUSPENSIONNDA
FABHALTAiptacopanCAPSULENDA
FemaraletrozoleTABLET, FILM COATEDNDA
Focalin XRdexmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASENDA
Focalin XRdexmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASENDA
Focalin XRdexmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASENDA
Focalin XRdexmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASENDA
Focalin XRdexmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASENDA
Focalin XRdexmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASENDA
Focalin XRdexmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASENDA
Focalin XRdexmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASENDA
GilenyaFingolimod hclCAPSULENDA
GilenyaFingolimod hclCAPSULENDA
Gleevecimatinib mesylateTABLETNDA
Gleevecimatinib mesylateTABLETNDA
Gleevecimatinib mesylateTABLETNDA
HYCAMTINtopotecan hydrochlorideINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONNDA
ILEVROnepafenacSUSPENSION/ DROPSNDA
IlariscanakinumabINJECTION, SOLUTIONBLA
JadenudeferasiroxTABLET, FILM COATEDNDA
JadenudeferasiroxTABLET, FILM COATEDNDA
JadenudeferasiroxTABLET, FILM COATEDNDA
JadenudeferasiroxGRANULENDA
JadenudeferasiroxGRANULENDA
JadenudeferasiroxGRANULENDA
KESIMPTAofatumumabINJECTION, SOLUTIONBLA
KISQALIribociclibTABLET, FILM COATEDNDA
KISQALIribociclibTABLET, FILM COATEDNDA
KISQALIribociclibTABLET, FILM COATEDNDA
KISQALI FEMARA CO-PACKletrozole and ribociclibKITNDA
KISQALI FEMARA CO-PACKletrozole and ribociclibKITNDA
KISQALI FEMARA CO-PACKletrozole and ribociclibKITNDA
KYMRIAHtisagenlecleucelINJECTION, SUSPENSIONBLA
KYMRIAHtisagenlecleucelINJECTION, SUSPENSIONBLA
LEQVIOinclisiranINJECTION, SOLUTIONNDA
LOCAMETZkit for the preparation of gallium Ga 68 gozetotideINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONNDA
LampreneClofazimineCAPSULE, LIQUID FILLEDNDA
Lotrelamlodipine besylate and benazepril hydrochlorideCAPSULENDA
Lotrelamlodipine besylate and benazepril hydrochlorideCAPSULENDA
Lotrelamlodipine besylate and benazepril hydrochlorideCAPSULENDA
Lotrelamlodipine besylate and benazepril hydrochlorideCAPSULENDA
MAXITROLneomycin sulfate, polymyxin b sulfate and dexamethasoneOINTMENTNDA
MAYZENTsiponimodTABLET, FILM COATEDNDA
MAYZENTsiponimodTABLET, FILM COATEDNDA
MAYZENTsiponimodTABLET, FILM COATEDNDA
MekinisttrametinibTABLET, FILM COATEDNDA
MekinisttrametinibTABLET, FILM COATEDNDA
MekinisttrametinibPOWDER, FOR SOLUTIONNDA
Myforticmycophenolic acidTABLET, DELAYED RELEASENDA
Myforticmycophenolic acidTABLET, DELAYED RELEASENDA
NeoralcyclosporineCAPSULE, LIQUID FILLEDNDA
NeoralcyclosporineCAPSULE, LIQUID FILLEDNDA
NeoralcyclosporineSOLUTIONNDA
PIQRAYalpelisibTABLETNDA
PIQRAYalpelisibTABLETNDA
PIQRAYalpelisibKITNDA
PLUVICTOlutetium Lu 177 vipivotide tetraxetanINJECTION, SOLUTIONNDA
PROMACTAeltrombopag olamineTABLET, FILM COATEDNDA
PROMACTAeltrombopag olamineTABLET, FILM COATEDNDA
PROMACTAeltrombopag olamineTABLET, FILM COATEDNDA
PROMACTAeltrombopag olamineTABLET, FILM COATEDNDA
PROMACTAeltrombopag olaminePOWDER, FOR SUSPENSIONNDA
PROMACTAeltrombopag olaminePOWDER, FOR SUSPENSIONNDA
RHAPSIDOremibrutinibTABLETNDA
RYDAPTRYDAPTCAPSULE, LIQUID FILLEDNDA
Ritalinmethylphenidate hydrochlorideTABLETNDA
Ritalinmethylphenidate hydrochlorideTABLETNDA
Ritalinmethylphenidate hydrochlorideTABLETNDA
Ritalin LAmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASENDA
Ritalin LAmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASENDA
Ritalin LAmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASENDA
Ritalin LAmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASENDA
SCEMBLIXasciminibTABLET, FILM COATEDNDA
SCEMBLIXasciminibTABLET, FILM COATEDNDA
SCEMBLIXasciminibTABLET, FILM COATEDNDA
-SECUKINUMABLIQUIDBULK INGREDIENT
SandimmunecyclosporineINJECTIONNDA
SandimmunecyclosporineCAPSULE, LIQUID FILLEDNDA
SandimmunecyclosporineCAPSULE, LIQUID FILLEDNDA
Sandostatinoctreotide acetateINJECTION, SOLUTIONNDA
Sandostatinoctreotide acetateINJECTION, SOLUTIONNDA
Sandostatinoctreotide acetateINJECTION, SOLUTIONNDA
Sandostatin LAR Depotoctreotide acetateKITNDA
Sandostatin LAR Depotoctreotide acetateKITNDA
Sandostatin LAR Depotoctreotide acetateKITNDA
SimulectbasiliximabINJECTION, POWDER, FOR SOLUTIONBLA
SimulectbasiliximabINJECTION, POWDER, FOR SOLUTIONBLA
-SomatropinINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
TABRECTAcapmatinibTABLET, FILM COATEDNDA
TABRECTAcapmatinibTABLET, FILM COATEDNDA
TOBREXtobramycinOINTMENTNDA
TRIESENCEtriamcinolone acetonideINJECTION, SUSPENSIONNDA
TYKERBlapatinibTABLETNDA
TafinlardabrafenibCAPSULENDA
TafinlardabrafenibCAPSULENDA
TafinlardabrafenibTABLET, FOR SUSPENSIONNDA
TasignanilotinibCAPSULENDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.